Clinical trial

Combination Therapy With VRC01 and 10-1074 in HIV-Infected Individuals Undergoing Sequential Treatment Interruptions

NCT03831945

Study summary

ClinicalTrials.gov

Combination Therapy With VRC01 and 10-1074 in HIV-Infected Individuals Undergoing Sequential Treatment Interruptions

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

BIOLOGICAL · Unmapped registry intervention VRC-HIVMAB060-00-AB (VRC01) Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention 10-1074 Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Normal Saline Placebo Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-04-04

PhasePHASE1

Conditions

HIVunresolved

Interventions

VRC-HIVMAB060-00-AB (VRC01)BIOLOGICAL

10-1074BIOLOGICAL

Normal Saline PlaceboBIOLOGICAL

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03831945 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.